FREDUN PHARMACEUTICALS
Back to Balance Sheet
|
FREDUN PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | |
|---|---|---|
| Deferred Tax Assets / Liabilities | ₹6.55 Cr | ₹4.48 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of FREDUN PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹6.55 Cr |
| Mar2025 | ₹4.48 Cr |
How is Deferred Tax Assets / Liabilities of FREDUN PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹6.55 Cr | 46.03 | |
| Mar2025 | ₹4.48 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹1,496.1 Cr | -1.1% | 1.1% | 192.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹473,509.0 Cr | 0.6% | 6% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,881.0 Cr | 1.2% | 10.5% | 7.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,832.0 Cr | -0.4% | 11% | 40.8% | Stock Analytics | |
| CIPLA | ₹113,894.0 Cr | -1.6% | -2.1% | -4.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,062.8 Cr | -4.6% | -14.8% | -8.4% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | -1.1% |
1.1% |
192.2% |
| SENSEX | -1.1% |
-0.2% |
-6.6% |
You may also like the below Video Courses